Tiny trial tests Human-Derived implant to fuse slipped spine bones
NCT ID NCT05961956
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study is testing a new implant called NVDX3, made from donated human cells, to help fuse spine bones in adults with a condition called degenerative lumbar spondylolisthesis (a slipped vertebra). Only 5 people are enrolled, and the implant is placed during a single surgery. The main goal is to check safety, not yet to prove it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NVDX3 (a bone-forming implant made from donated human cells)
- What this could lead to
- If successful, this could lead to a new way to fuse spine bones using a single implant, potentially reducing the need for additional bone grafts.
- What could go wrong
- This is a very early, tiny study with only 5 people, so results may not apply to everyone. The implant is new and its safety and effectiveness are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEGENERATIVE LUMBAR SPONDYLOLISTHESIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier de Luxembourg
Luxembourg, 1210, Luxembourg
More trials for these conditions
Other studies related to the condition(s) this trial covers.